GlassScriptPhysician profile
Thazin Aung
NPI 1215331558
$8,886.45
in general payments reported to CMS, 2019-2025
11 companies · $1,382 in 2025
The $1,382 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,348 · 2020: $41.10 · 2021: $435 · 2022: $289 · 2023: $304 · 2024: $5,087 · 2025: $1,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,720 · Food and Beverage: $1,070 · Travel and Lodging: $871 · Entertainment: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,720.00 |
| Food and Beverage | $1,069.97 |
| Travel and Lodging | $870.67 |
| Entertainment | $112.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $5,809.88 | 2024-2025 | Synergeyes Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $1,282.95 | 2019-2025 | Acuvue |
| Johnson & Johnson Surgical Vision, INC. | $1,151.33 | 2019 | |
| Dompe US, INC. | $121.27 | 2025 | Oxervate |
| Alcon Vision LLC | $115.14 | 2021-2024 | Dailies Total1, Dailies, Precision 1 |
| Optos, INC. | $112.98 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $110.15 | 2022 | |
| Plexus Optix, INC. | $95.87 | 2021 | |
| Heru, INC. | $55.20 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Abb Con-Cise Optical Group LLC | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thazin Aung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.